Colorado Plan to Reduce Prescription Drug Abuse



Similar documents
Colorado Consortium for Prescription Drug Abuse Prevention:

Flagship Priority: Mental Health and Substance Abuse

Colorado Prescription Drug Monitoring Program. Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy

Substance Use: Addressing Addiction and Emerging Issues

State Substance Abuse Agencies and Prescription Drug Abuse Initial Results from a NASADAD Membership Inquiry

Vermont Prescription Drug Abuse Workgroup Final Report Workgroup Recommendations

Reducing Prescription Drug Abuse: Lessons Learned from an NGA Policy Academy

Our Mission. How does Colorado Medicaid Work? Objectives

Prescription Opioid Overdose & Misuse in Oregon

Colorado Substance Use and Recommendations Regarding Marijuana Tax Revenue

ARIZONA SUBSTANCE ABUSE PARTNERSHIP Governor s Office for Children, Youth and Families

STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council

For a Healthier America: Reducing Prescription Drug Misuse and Abuse

PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE

WHAT WE KNOW. Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE

Poisoning Prevention

The Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community

Recommendations of the Governor s Task Force on Prescription Drug and Heroin Abuse

QUEEN ANNE S COUNTY STRATEGIC PLAN ALCOHOL AND DRUG ABUSE SERVICES

Prescription Drug Monitoring Programs: Adopting Best & Promising PDMP Practices

IHS National Prescription Drug Abuse Workgroup

VERMONT2007. Vermont Prescription Monitoring Program. Report to the Legislature on Act 205 January 15, 2008

Governor s Task Force on Mental Health and Substance Use.

Massachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District

The Cost of Pain and Economic Burden of Prescription Misuse, Abuse and Diversion. Angela Huskey, PharmD, CPE

UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths

Prescription Drug Abuse and Pain Management Clinics 2015 Report to the 109 th Tennessee General Assembly

Prescription Drug Monitoring Program Center of Excellence at Brandeis

DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services. NEW products from the Medicare Learning Network (MLN)

Annual Harold Rogers Prescription Drug Monitoring Program onitoring. Commissioner Cheryl Bartlett, RN Massachusetts Department of Public Health

Preventing Prescription Drug Abuse: An Important Role for State Injury Prevention Programs

JAN poisonings, commonly referred to as drug overdoses, are one of. the leading causes of injury-related mortality in Hawaii.

Mayor s Task Force On Prescription Painkiller Abuse

The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section

2015 REPORT Steven W. Schierholt, Esq. Executive Director

Report to the Legislature: Interstate Prescription Data Exchange MN Prescription Monitoring Program

Preventing Opioid Abuse and Consequences, Including Heroin, in New England: An Opportunity for Cross-State Collaboration

COMMONWEALTH of VIRGINIA PRESCRIPTION DRUG ABUSE REDUCTION STRATEGY. In Conjunction With THE NATIONAL GOVERNORS ASSOCIATION

MEETING OF THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE MEETING: RISKS AND BENEFITS OF HYDROCODONE COMBINATION ANALGESIC PRODUCTS

Evaluating Options for the Integration of Electronic Medical Records With the Vermont Prescription Monitoring System

VERMONT2008 Vermont Prescription Monitoring Program

CAPITOL research. Interstate Information Sharing: Prescription Drug Monitoring Programs

State of New York Executive Chamber Andrew M. Cuomo Governor

Prescription Drug Monitoring Program Administrators Guide for Training Law Enforcement

New Hampshire s System for Substance Abuse Prevention Efforts and Services

Prescription Drug Abuse

Rx and Heroin Abuse :Taking Action

Drug Diversion. Controlled Substance Prescribing and Diversion

Northwest Primary Care Practitioners Presentation Tackling the Opioid Epidemic in Oregon

5/31/2015. Statement of Need:

Washington State Interagency Opioid Working Plan

State of Washington Substance Abuse Prevention and Mental Health Promotion

The Public Health and Safety Challenges of Treating Chronic Pain: The Medical Perspective. A Proposed CMS Platform

Testimony on Opioid Overdose Prevention. Daniel Raymond, Policy Director, Harm Reduction Coalition

State of Colorado. Substance Abuse Trend and Response Task Force

EPIDEMIC: RESPONDING TO AMERICA S PRESCRIPTION DRUG ABUSE CRISIS

NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS

Prescription Drug Monitoring Programs: A State Policy to Address Prescription Opioid Poisonings. Michael Kim, MPH April 30, 2012

Colorado Maternal and Child Health Local Action Plan (updated 2/18/2016) 10/1/16-9/30/18 Local Agency Name: Priority Lead

Harold Rogers Prescription Drug Monitoring Program

Pennsylvania s ABC-MAP Program

Prescriber Behavior, Pain Treatment and Addiction Treatment

DEA REGISTRATION FEES FACT SHEET

TESTIMONY. March 17, Rutland, VT

Technical Assistance Guide No Funding Options for Prescription Drug Monitoring Programs

Dear Chairman Hardy, Chairman Oscarson, and Members of the Committee:

Colorado. Contact Information. Statistics. Technological Capabilities

State Substance Abuse Agencies, Prescription Drugs, and. Heroin Abuse: Results from a NASADAD Membership Inquiry

Testimony of The New York City Department of Health and Mental Hygiene. before the

Maternal and Child Health Issue Brief

Part 1: Opioids and Overdose in the U.S. and New Mexico. Training: New Mexico Pharmacist Prescriptive Authority for Naloxone Protocol 7/15/2015

PRESCRIPTION PAINKILLER OVERDOSES

Trends of Opioid Misuse and Diversion: Lessons from the United States

New Mexico. Contact Information. Statistics. Technological Capabilities

Prescription Opioid Use and Opioid-Related Overdose Death TN,

A New Generation of Prescription Monitoring Programs: Best & Promising Practices

Bureau of Justice Assistance. Prescription Drug Monitoring Program Performance Measures Report: January 2009 through June 2012

Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas

EPIDEMIC: RESPONDING TO AMERICA S PRESCRIPTION DRUG ABUSE CRISIS

ANNE ARUNDEL COUNTY, MARYLAND STRATEGIC PLAN FOR ALCOHOL AND DRUG ABUSE Fiscal Years 2014 & 2015 January 2015 Update

Office of ehealth Innovation. ehealth Commission Meeting February 17, 2016

The Current State of Drug Abuse Across the Nation. December 12, 2015

UTAH DRUG CONTROL UPDATE. Substance Abuse Treatment Admissions Data

Opioid Prescribing Practices and Pain Management: Role of FDA Douglas C. Throckmorton, MD Deputy Director for Regulator Programs, CDER, FDA

SAMHSA Initiatives to Educate Prescribers and Consumers and Treatment Resources

Prescription Drug Monitoring Programs

Maryland. Department of Health and Mental Hygiene, Alcohol and Drug Abuse Administration Substance Abuse Agency

SAMHSA, YOU & ME. Faces & Voices of Recovery ARCO Executive Directors Leadership Academy November 15, 2014

What is an opioid? Why address opioid use in your county? Support the Prevention Agenda by Preventing Non-Medical Prescription Opioid Use and Overdose

Health Care Costs from Opioid Abuse: A State-by-State Analysis

Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015

Idaho. Contact Information. Fax: (208) Statistics. Technological Capabilities

Stephenie W. Colston, M.A Ivanhoe Road Tallahassee, FL Telephone: (850)

Creating Secure Medicine Return Programs to Reduce Misuse of Medicines in King County & Washington State

9/8/2014 EPIDEMIOLOGY PUBLIC HEALTH INTERVENTIONS FOR NEONATAL ABSTINENCE SYNDROME DISCLOSURE OBJECTIVES. No financial COI to disclose

How To Understand The Ppa

Prescription Drug Abuse. Katherine E. Schmidt. IHEC Intern - Fall 2010

National Governors Association Policy Academy on Prescription Drug Abuse Prevention. State of Nevada Draft Plan Recommendations

Deborah F. Toth-Dennis 109 Water Land Ct. Frederick, Maryland H C ohanakepola@prodigy.net

(S.4) It is hereby enacted by the General Assembly of the State of Vermont: (1) According to the Centers for Disease Control and Prevention:

Transcription:

Colorado Plan to Reduce Prescription Drug Abuse September 2013 Kelly Perez Policy Advisor Office of Governor John Hickenlooper

The Colorado Team (2012/2013) Christine Adams Statistical Analyst/Researcher Colorado Department of Public Safety Wendy Anderson Board of Pharmacy Program Director Colorado Department of Regulatory Agencies Division of Professions and Occupations David Blake Deputy Attorney General Legal Policy and Government Affairs Office of the Colorado Attorney General Shannon Breitzman Branch Director Injury, Suicide and Violence Prevention Colorado Department of Public Health & Environment Lisa Clements Director Colorado Department of Human Services Office of Behavioral Health Liza Fox-Wylie Director, Health Information Technology Governor s Office of Information Technology Tia Johnson Administrator Prescription Drug Monitoring Program Colorado Department of Regulatory Agencies Division of Professions and Occupations Jim Leonard DUR Pharmacist Department of Health Care Policy and Financing Stan Paprocki Director of Community Prevention Programs Division of Behavioral Health Colorado Department of Human Services Kelly Perez Human Services Policy Advisor Governor s Office of Policy and Research Cathy Traugott Pharmacy Section Manager Department of Health Care Policy and Financing Please direct inquiries to: Kelly Perez Kelly.Perez@state.co.us Zach Pierce Zachary.Pierce@state.co.us Rob Valuck Robert.Valuck@ucdenver.edu Colorado Plan to Reduce Prescription Drug Abuse September 2013 3

Acknowledgements Appreciation is extended to the leadership and staff of the following agencies, offices and partnering organizations, without whose diligent efforts and essential contributions the creation of this strategic plan would not have been possible. Arapahoe House Centers for Disease Control and Prevention Colorado Attorney General s Office (AG) Colorado Dental Association (CDA) Colorado Department of Human Services (CDHS) Colorado Department of Public Health and Environment (CDPHE) Colorado Department of Public Safety (CDPS) Colorado Department of Regulatory Agencies (DORA) Colorado Division of Behavioral Health (CDBH) Colorado Division of Workers Compensation, CMS Colorado House of Representatives Colorado Medical Society (CMS) Colorado Pharmacists Society (CPS) Colorado School of Public Health (CSPH) Colorado State Senate COPIC (formerly Colorado Physicians Insurance Company) Department of Health Care Policy and Finance (HCPF) Drug Enforcement Administration (DEA) Governor s Office of Policy and Research Governor s Office of Information Technology (OIT) Homeland Security & Public Safety Division National Governors Association (NGA) Peer Assistance Services Purdue Pharma RADARS/Rocky Mountain Poison and Drug Center (RADARS/RMPDC) Screening, Brief Intervention, and Referral to Treatment (SBIRT) The Partnership at Drugfree.org University of Colorado (CU) University of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences Colorado Plan to Reduce Prescription Drug Abuse September 2013 4

Table of Contents Executive Summary...6 Colorado Team...8 NGA Policy Academy to Reduce Prescription Drug Abuse...8 Key Components...9 Glossary of Acronyms...11 Table 1: General Recommendations...12 Colorado Consortium to Reduce Prescription Drug Abuse...13 Table 2: Colorado Plan to Reduce Prescription Abuse 12-month Action Plan...14 Colorado Plan to Reduce Prescription Drug Abuse September 2013 5

Executive Summary The abuse of prescription drugs is the fastest growing drug problem in the United States, particularly among adolescents. To combat this growing problem, the National Governors Association (NGA) hosted a year-long Policy Academy to Reduce Prescription Drug Abuse. The Policy Academy, co-chaired by Governors Hickenlooper (D-Colorado) and Bentley (R-Alabama), supported the development of comprehensive state strategic plans to reduce prescription drug abuse. States participated in a competitive grant process and Colorado, along with Alabama, Oregon, New Mexico, Arkansas, Kentucky and Virginia were each awarded $45,000 grants to facilitate the strategic planning process. Percent of Coloradans who misused prescription opioids in the past year 4.6% NATIONAL AVERAGE According to survey data released in 2013 from the National Survey on Drug Use and Health (SAMHSA) Colorado ranks second worst among all states for prescription drug misuse. More than 255,000 Coloradans misuse prescription drugs, and deaths involving the use of opioids nearly quadrupled between 2000 and 2011. The economic expenditures associated with prescription drug abuse are significant, and include costs attributed to lost productivity, criminal justice, treatment, and medical complications. The challenge for Colorado in addressing prescription drug abuse is to implement a comprehensive and coordinated statewide strategy that simultaneously restricts access to prescription drugs for illicit use while ensuring access for those who legitimately need them. 255,000 COLORADANS AGED 12 + 6% 79,000 COLORADANS AGED 18-25 14% 144,600 COLORADANS AGED 26 + 4.4% 1 1 Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. (January 8, 2013). The NSDUH Report: State Estimates of Nonmedical Use of Prescription Pain Relievers. Rockville, MD. Colorado Plan to Reduce Prescription Drug Abuse September 2013 6

As articulated in the April 2013 Colorado State of Health: Colorado s Commitment to Become the Healthiest State, the Hickenlooper administration has pledged to reduce the prevalence of non-medical use of prescription pain medications 2 in Colorado by 3.5% (92,000 Coloradans) by 2016. The adoption of a strategic plan represents an important step toward achieving that goal. Sustained coordination and collaboration across the medical community, state and local law enforcement, public health, human services, and community groups and Colorado s Legislature is critical to reverse trends in prescription drug abuse and position Colorado as the nation s healthiest state. 2016 GOAL: PREVENT 92,000 Coloradans from misusing opioids 255,000 COLORADANS AGED 12 + 6% = 1000 PEOPLE 163,000 COLORADANS AGED 12 + 92,000 COLORADANS AGED 12 + PREVENTED 3.5% minus = FROM MISUSING OPIOIDS 2011-2012 2016 TARGET 2 Colorado Governor s Office. The State of Health: Colorado s Commitment to Become the Healthiest State. (April, 2013). Denver, CO. Colorado Plan to Reduce Prescription Drug Abuse September 2013 7

Colorado Team Recognizing the need for a multi-system approach, the Governor s office assembled an initial Colorado Team that included representation from the Colorado departments of Human Services, Public Health and Environment, Public Safety, Regulatory Agencies, and Health Care Policy and Finance as well as the Colorado Attorney General s Office, the Governor s Office of Information Technology and the Policy Office. The eight-member team convened to learn about the myriad issues and national context of prescription drug abuse and developed an initial framework to address prescription drug abuse in Colorado. Policy staff then engaged with provider and other community groups including the Colorado Medical Society, the Colorado Prescription Abuse Task Force, the State Meth Task Force (now named Substance Abuse Trends and Response Task Force), Purdue Pharma, the Researched, Abuse, Diversion and Addiction-Related System (RADARS), and others to determine if the initial framework reflected the appropriate focus areas to reduce the problem. The team considered opportunities to strengthen and leverage existing state efforts. A key learning for staff was the recognition that involving a range of experts and stakeholders in an honest inquiry process led to authentic engagement and productive collaboration. Much of the initial information gathering and the NGA Policy Academy efforts occurred during the 2013 Legislative Session making it extremely challenging for State Legislators, who had been active in reducing prescription drug abuse in the past, to actively participate in this process. It is expected that State Legislators will be increasingly engaged in building on these efforts to reduce prescription drug abuse in Colorado. NGA Policy Academy to Reduce Prescription Drug Abuse The recommendations that comprise the Colorado Plan to Reduce Prescription Drug Abuse issue come from four separate meetings involving nearly 200 strategically selected stakeholders as well as from national experts: The first NGA Policy Academy was held in October 2012 in Montgomery, Alabama and provided the national context, five NGA-recommended focus areas, and best practices for reducing prescription drug abuse. The March 2013 Round Tables event was held at the University Of Colorado School of Pharmacy. Stakeholders from across Colorado were invited to contribute their expertise in one of five focus areas (Provider Education, the Prescription Drug Monitoring Program, Safe Disposal, Data and Surveillance, and Public Education). During that process, Treatment was identified and added as a crucial component for a comprehensive public health approach, deemed most effective to impact the issue. As in most states, this is a difficult focus area to add as the current substance abuse treatment system is not well connected to other systems (health, law enforcement, mental health) so there is much to assess. In addition to these focus areas, a coordinating body was suggested to help facilitate and house the Colorado Plan to Reduce Prescription Drug Abuse, as well as to increase Colorado s prevention funding opportunities nationally. Colorado Plan to Reduce Prescription Drug Abuse September 2013 8

The recommendations from the Round tables were circulated to all invited stakeholders to ensure their accuracy and appropriateness. Prioritizing and sequencing the recommendations into what could be accomplished in one year, was the focus of the April 2013 Colorado Policy Academy to Reduce Prescription Drug Abuse. This meeting resulted in a draft strategic plan and timeline circulated to Colorado Team members and agency/ office heads and then taken to the second NGA Policy Academy to Reduce Prescription Drug Abuse in May 2013. Key Components The Colorado Plan to Reduce Prescription Abuse reflects and perpetuates the essential multi-system nature of the approach to reducing prescription drug abuse in Colorado. The plan includes the following components: 1) General Recommendations (See Table 1) 2) Establishment of the Colorado Consortium to Reduce Prescription Drug Abuse (See Graphic) This cooperative, interagency/interuniversity framework is designed to facilitate the collaboration and implementation of the strategic plan by interested parties and agencies. The Consortium is housed in the University of Colorado (CU) Skaggs School of Pharmacy and Pharmaceutical Sciences at the Anschutz Medical Campus (which houses the School of Pharmacy, the Colorado School of Public Health, Colorado State University, the University of Northern Colorado, the CU School of Medicine, and the CU College of Nursing). The Consortium provides a statewide, inter-university/inter-agency network and serves as the strategic lead for the Colorado Rx plan with active participation from the Governor s Policy Office and various state agencies and offices. The educational and medical communities are well positioned to address many of Colorado s key Rx abuse issues, and the partnerships facilitated by the newly formed Consortium will be crucial in attaining optimum outcomes and increased federal funding to combat the growing problem. As the coordinating center, the Consortium will house each focus-area workgroup. Each workgroup will be co-chaired by an agency/community and university representative. To avoid duplication of efforts, the Consortium will work closely with both the Colorado Rx Abuse Task Force (housed at Peer Assistance Services, a private 501c3, and managed by OBH at CDHS the state authority for substance abuse prevention) and the Substance Abuse Trend and Response Task Force (which is co-chaired by Attorney General Suthers and includes representation from CDPHE, CDHS and local law enforcement). Increased coordination with state and local law enforcement, the AG s Office, and others working closely on these issues will increase the likelihood of improved outcomes. Colorado Plan to Reduce Prescription Drug Abuse September 2013 9

Developing an effective strategy requires balancing the needs and concerns of patients, public health, law enforcement, and the medical community among others. Fortunately, the Colorado State Attorney General has a special interest in this area and has pledged resources to fund the public awareness component of a comprehensive approach to reducing the misuse and abuse of controlled substances including prescription opioids. Attorney General Suthers recognizes that a comprehensive approach involves various stakeholders, including law enforcement and prosecutors, in the solution. Regardless of whether a controlled substance is prescribed by a health care provider, or obtained through a fraudulent prescription or some other illicit means, the law enforcement community can serve a vital role in investigating and prosecuting the most egregious offenders. Leadership of the Office of the Attorney General and its Criminal Justice Section stands front and center as part of law enforcement s emerging efforts to establish a coordinated response to this growing epidemic. The Office of the Attorney General is collaborating at the state and local levels, and working in concert with Federal partners at both the US Attorney s Office and the Drug Enforcement Administration to jointly seek a viable reduction in abuse of these highly addictive prescription medications. 3) The Colorado Plan to Reduce Rx Drug Abuse: 12-month Action Plan includes specific, achievable recommendations (See Table 2). The action plan, together with the general recommendations, issued from two separate meetings (the March Round tables at the CU School of Pharmacy and the April Colorado Policy Academy meeting. The plan details the agreed-upon action items that can reasonably be accomplished within one year, although it is expected that the work will continue beyond 2014. Governor Hickenlooper approved both the Strategic Plan and the Consortium to support implementation of the plan in July 2013. A September 2013 event is scheduled at the University of Colorado Skaggs School of Pharmacy to officially launch the center, to describe the center s logistical framework and how it is designed to facilitate the continued efforts of the work groups. Colorado Plan to Reduce Prescription Drug Abuse September 2013 10

Glossary of Acronyms AARP (Formerly the American Association of Retired Persons) Best Management Practices (BMP) Colorado Attorney General s Office (AG) Colorado Dental Association (CDA) Colorado Department of Human Services (CDHS) Colorado Department of Public Health and Environment (CDPHE) Colorado Department of Public Safety (CDPS) Colorado Department of Regulatory Agencies (DORA) Colorado Division of Behavioral Health (CDBH) Colorado Medical Society (CMS) Colorado Nurses Association (CNA) Colorado Pharmacists Society (CPS) Colorado School of Public Health (CSPH) COPIC (formerly Colorado Physicians Insurance Company) Denver Epidemiology Workgroup (EPI Workgroup) Department of Health Care Policy and Finance (HCPF) Drug Enforcement Administration (DEA) Governor s Office of Information Technology (OIT) National Governors Association (NGA) The Pharmaceutical Research and Manufacturers of America (PhRMA) RADARS/Rocky Mountain Poison and Drug Center (RADARS/RMPDC) Screening, Brief Intervention, and Referral to Treatment (SBIRT) University of Colorado (CU) United States Environmental Protection Agency (USEPA) United States Geological Survey (USGS) Colorado Plan to Reduce Prescription Drug Abuse September 2013 11

Table 1: Recommendations to Reduce Prescription Drug Misuse and Abuse in Colorado Colorado Consortium Provider & Prescriber Education PDMP Disposal The Colorado Consortium, housed in the CU School of Pharmacy, will serve as the operational lead for the CO Plan to Reduce Rx Abuse with participation from the Governor s Policy Office, a variety of state agencies, and community partners. The Consortium will help to facilitate and implement Workgroup Recommendations mentioned below. Change state board policies (or rules) for all DORA-licensed prescribers to include pain management guidelines. Enlist and support DORA to provide education about the existence and utilization of PDMP as part of the licensing processes for prescribers and pharmacists. Form taskforce with representation from various agencies to examine the use of PDMP as a public health tool. Improve usability and appropriate accessibility of the PDMP system through the use of information technology and increased stakeholder access. Expand take-back program in law enforcement agencies develop permanent drop-off sites with Law Enforcement. Expand take-back program to pharmacies (pending DEA approval). Establish Colorado guidelines on flushing. Public Awareness Data & Analysis Develop (or utilize existing) social marketing campaign that targets the General Public and overcomes existing obstacles and misperceptions. Develop (or utilize existing) social marketing campaign that targets Youth and Young Adults (12-25 year olds) and overcomes existing obstacles and misperceptions. Map out all sources of data related to prescription drug use, misuse and overdose in the state in order to monitor trends, educate the public and inform decision making by multiple stakeholders. Identify other efforts that successfully use crosswalks between diverse data sources and successfully standardize their data collection tools across agencies.

Colorado Consortium for Prescription Drug Abuse Prevention A coordinated, statewide, interuniversity / interagency network Prescriber and Provider Education Workgroup Agency Co-Chair: DORA / HCPF designee PDMP Workgroup Agency Co-Chair: DORA University Co-Chair Treatment Workgroup Agency Co-Chair: CDHS / HCPF designee University Co-Chair Governor Policy Lead University Co-Chair Safe Disposal Workgroup Coordinating Center, University of Colorado School of Pharmacy Advisory Board CO Rx Abuse Task Force CO Attorney General Substance Abuse Trend & Response Task Force Agency Co-Chair: CDPHE designee with Law Enforcement Rep. University Co-Chair: CSPH Public Awareness Workgroup Agency Co-Chair: OBH designee University Co-Chair: CSPH Data/Analysis Workgroup Agency Co-Chair: CDHS / CDPHE/HCPF designee University Co-Chair Colorado Plan to Reduce Prescription Drug Abuse September 2013 CO Legislature LEGEND = Exis+ng = New

RECOMMENDATIONS PUBLIC AWARENESS (NOTE: The following action steps apply to campaigns targeting the general population and targeting youth/young adults 12-25 year olds) PROVIDER AND PRESCRIBER EDUCATION: Board Policies PROVIDER AND PRESCRIBER EDUCATION: Retrain Existing Providers (Must do) PROVIDER AND PRESCRIBER EDUCATION: Educate Students & Trainers Colorado Plan to Reduce Rx Abuse: 12- Month Strategic Action Plan (Table 3) 4 th Quarter (April, May, June 2013) Develop core leadership group Explore: 1. Existing campaigns 2. Messaging for CO 3. Resources / partners Request funding from AG's office Identify sustainable funding Marketing plan for current prescriber education (including PDMP) Convene workgroup to look at prescriber education best practices Continue implementation of current evaluation plans for SBIRT and current online course CSPH Create subgroup for prescriber education student curriculum. This includes: Exam Vendors; and School accrediting bodies by making recommendation to NGA Request Governor talk to each university president to align curriculum with new guidelines 1 st Quarter (July, Aug, Sept 2013) Develop or identify messaging Set metrics Request Governor to support pain management policy State boards meet to draft policy Find funding to update prescriber education opportunities Workgroup reviews existing education to hit 4 areas (best practice in controlled substance prescribing, pain management, patient safety, and re-training) and ID gaps across professions. New prescriber guidelines incorporated into all prescriber student curriculum Agreement to align student curriculum with new prescriber guidelines 2 nd Quarter (Oct, Nov, Dec 2013) Implement DORA Division of Professions and Occupations (DPO) draft guidelines complete Update and customize educational content for prescribers Update and customize educational content for prescribers 3 rd Quarter (Jan, Feb, Mar 2014) Evaluate and tweak Public comment and stakeholder meetings done Produce new prescriber education program Create evaluation plan for prescriber education opportunities with data group CO In-State Policy Academy (4/25/13) Plan approved by Governor 7-13 4 th Quarter (April, May, June 2014) Final policies or rules in place Release updated and finalized content for prescriber education Ongoing review with new guidelines after final rule Align content with new guidelines after final policies Take new prescriber education to curriculum committee with approval PROVIDER AND PRESCRIBER EDUCATION: Change Payment by Medicaid and State Employee Insurers (Wish list) Change Medicaid, state, and work compensation payers to align with and incentivize new Rx guidelines.

Colorado Plan to Reduce Rx Abuse: 12-Month Strategic Action Plan (cont.) CO In-State Policy Academy (4/25/13) Plan approved by Governor 7-13 RECOMMENDATIONS 4 th Quarter (April, May, June 2013) 1 st Quarter (July, Aug, Sept 2013) 2 nd Quarter (Oct, Nov, Dec 2013) 3 rd Quarter (Jan, Feb, Mar 2014) 4 th Quarter (April, May, June 2014) Specify requirements and goals for inventory Launch portal DATA AND ANALYSIS (RECOMMEND: Map out all sources of data related to prescription drug abuse, misuse, and overdose in the state (e.g., supply, prescribing, dispensing, MDs, pharmacies, law enforcement, disposal, manufacturers) in order to monitor trends, educate the public, and inform decision making by multiple stakeholders) Determine what we want included and why Research existing portals (e.g., DataColorado.gov) Identify the home (e.g. OIT, CDPHE, Center U of C) Create the portal (build it, maintain, sustain) Define vision what are we looking for? Explore other states (e.g., Kentucky s KASPER, South Carolina s) Develop a proposal for achieving the vision in phases Define data questions Explore Colorado-based data sharing efforts, such as P-20 education initiative DISPOSAL Continue to expand National Take Back sites and participation Strengthen DEA, EPA, CDPHE and law enforcement partnerships federal/state/local Identify stakeholders Identify data needs for PDMP from stakeholders Interagency agreements Short term improved data sharing under current law Prescription Drug Monitoring Program (PDMP) Create task force with CDPHE, HCPF, and DORA Conduct stakeholder meeting Identify data needs for PDMP from stakeholders Convene stakeholders to identify barriers and needs Usability: In short term, improve user interface (contract options) Usability: Long-term, combined with HIE/Legislative strategy is likely needed Submit needs to vendor